157 related articles for article (PubMed ID: 28269951)
21. Bridging data models and terminologies to support adverse drug event reporting using EHR data.
Declerck G; Hussain S; Daniel C; Yuksel M; Laleci GB; Twagirumukiza M; Jaulent MC
Methods Inf Med; 2015; 54(1):24-31. PubMed ID: 25487120
[TBL] [Abstract][Full Text] [Related]
22. Pharmacovigilance in children: detecting adverse drug reactions in routine electronic healthcare records. A systematic review.
Black C; Tagiyeva-Milne N; Helms P; Moir D
Br J Clin Pharmacol; 2015 Oct; 80(4):844-54. PubMed ID: 25819310
[TBL] [Abstract][Full Text] [Related]
23. Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system.
Norén GN; Bergvall T; Ryan PB; Juhlin K; Schuemie MJ; Madigan D
Drug Saf; 2013 Oct; 36 Suppl 1():S107-21. PubMed ID: 24166228
[TBL] [Abstract][Full Text] [Related]
24. Enhancing adverse drug event detection in electronic health records using molecular structure similarity: application to pancreatitis.
Vilar S; Harpaz R; Santana L; Uriarte E; Friedman C
PLoS One; 2012; 7(7):e41471. PubMed ID: 22911794
[TBL] [Abstract][Full Text] [Related]
25. Learning temporal weights of clinical events using variable importance.
Zhao J; Henriksson A
BMC Med Inform Decis Mak; 2016 Jul; 16 Suppl 2(Suppl 2):71. PubMed ID: 27459993
[TBL] [Abstract][Full Text] [Related]
26. Pharmacovigilance using clinical notes.
LePendu P; Iyer SV; Bauer-Mehren A; Harpaz R; Mortensen JM; Podchiyska T; Ferris TA; Shah NH
Clin Pharmacol Ther; 2013 Jun; 93(6):547-55. PubMed ID: 23571773
[TBL] [Abstract][Full Text] [Related]
27. Timeline representation of clinical data: usability and added value for pharmacovigilance.
Ledieu T; Bouzillé G; Thiessard F; Berquet K; Van Hille P; Renault E; Polard E; Cuggia M
BMC Med Inform Decis Mak; 2018 Oct; 18(1):86. PubMed ID: 30340483
[TBL] [Abstract][Full Text] [Related]
28. Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources.
Geva A; Abman SH; Manzi SF; Ivy DD; Mullen MP; Griffin J; Lin C; Savova GK; Mandl KD
J Am Med Inform Assoc; 2020 Feb; 27(2):294-300. PubMed ID: 31769835
[TBL] [Abstract][Full Text] [Related]
29. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record.
Tillman EM; Suppes SL; Feldman K; Goldman JL
J Clin Pharmacol; 2021 Feb; 61(2):181-186. PubMed ID: 32776356
[TBL] [Abstract][Full Text] [Related]
30. Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams.
Eshleman R; Singh R
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):335. PubMed ID: 27766937
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records.
Liu M; McPeek Hinz ER; Matheny ME; Denny JC; Schildcrout JS; Miller RA; Xu H
J Am Med Inform Assoc; 2013 May; 20(3):420-6. PubMed ID: 23161894
[TBL] [Abstract][Full Text] [Related]
32. Predictive modeling of structured electronic health records for adverse drug event detection.
Zhao J; Henriksson A; Asker L; Boström H
BMC Med Inform Decis Mak; 2015; 15 Suppl 4(Suppl 4):S1. PubMed ID: 26606038
[TBL] [Abstract][Full Text] [Related]
33. A Data-Driven Reference Standard for Adverse Drug Reaction (RS-ADR) Signal Assessment: Development and Validation.
Lee S; Lee JH; Kim GJ; Kim JY; Shin H; Ko I; Choe S; Kim JH
J Med Internet Res; 2022 Oct; 24(10):e35464. PubMed ID: 36201386
[TBL] [Abstract][Full Text] [Related]
34. Selecting information in electronic health records for knowledge acquisition.
Wang X; Chase H; Markatou M; Hripcsak G; Friedman C
J Biomed Inform; 2010 Aug; 43(4):595-601. PubMed ID: 20362071
[TBL] [Abstract][Full Text] [Related]
35. Mining clinical text for signals of adverse drug-drug interactions.
Iyer SV; Harpaz R; LePendu P; Bauer-Mehren A; Shah NH
J Am Med Inform Assoc; 2014; 21(2):353-62. PubMed ID: 24158091
[TBL] [Abstract][Full Text] [Related]
36. The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.
de Bie S; Coloma PM; Ferrajolo C; Verhamme KM; Trifirò G; Schuemie MJ; Straus SM; Gini R; Herings R; Mazzaglia G; Picelli G; Ghirardi A; Pedersen L; Stricker BH; van der Lei J; Sturkenboom MC;
Br J Clin Pharmacol; 2015 Aug; 80(2):304-14. PubMed ID: 25683723
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of an automated knowledge base for identifying drug adverse reactions.
Voss EA; Boyce RD; Ryan PB; van der Lei J; Rijnbeek PR; Schuemie MJ
J Biomed Inform; 2017 Feb; 66():72-81. PubMed ID: 27993747
[TBL] [Abstract][Full Text] [Related]
38. Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases.
Whalen E; Hauben M; Bate A
Drug Saf; 2018 Jun; 41(6):565-577. PubMed ID: 29468602
[TBL] [Abstract][Full Text] [Related]
39. Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.
Schuemie MJ; Gini R; Coloma PM; Straatman H; Herings RM; Pedersen L; Innocenti F; Mazzaglia G; Picelli G; van der Lei J; Sturkenboom MC
Drug Saf; 2013 Oct; 36 Suppl 1():S159-69. PubMed ID: 24166232
[TBL] [Abstract][Full Text] [Related]
40. Drug-induced hypersensitivity: A 5-year retrospective study in a hospital electronic health records database.
Mendes D; Alves C; Loureiro M; Fonte A; Batel-Marques F
J Clin Pharm Ther; 2019 Feb; 44(1):54-61. PubMed ID: 30069891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
